BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 10901699)

  • 1. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
    Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
    Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by n-propylxanthate.
    Kent UM; Yanev S; Hollenberg PF
    Chem Res Toxicol; 1999 Apr; 12(4):317-22. PubMed ID: 10207119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 17-alpha-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites.
    Kent UM; Mills DE; Rajnarayanan RV; Alworth WL; Hollenberg PF
    J Pharmacol Exp Ther; 2002 Feb; 300(2):549-58. PubMed ID: 11805216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5.
    Lin HL; Kent UM; Hollenberg PF
    J Pharmacol Exp Ther; 2005 Apr; 313(1):154-64. PubMed ID: 15608076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective mechanism-based inactivation of cytochromes P-450 2B1 and P-450 2B6 by a series of xanthates.
    Yanev S; Kent UM; Pandova B; Hollenberg PF
    Drug Metab Dispos; 1999 May; 27(5):600-4. PubMed ID: 10220489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of benzyl isothiocyanate on rat and human cytochromes P450: identification of metabolites formed by P450 2B1.
    Goosen TC; Mills DE; Hollenberg PF
    J Pharmacol Exp Ther; 2001 Jan; 296(1):198-206. PubMed ID: 11123381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism-based inactivation of cytochrome P450 2B1 by N-benzyl-1-aminobenzotriazole.
    Kent UM; Bend JR; Chamberlin BA; Gage DA; Hollenberg PF
    Chem Res Toxicol; 1997 May; 10(5):600-8. PubMed ID: 9168259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism-based inactivation of human cytochrome P450 2B6 by phencyclidine.
    Jushchyshyn MI; Kent UM; Hollenberg PF
    Drug Metab Dispos; 2003 Jan; 31(1):46-52. PubMed ID: 12485952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of N,N',N"-triethylenethiophosphoramide by CYP2B1 and CYP2B6 results in the inactivation of both isoforms by two distinct mechanisms.
    Harleton E; Webster M; Bumpus NN; Kent UM; Rae JM; Hollenberg PF
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1011-9. PubMed ID: 15121764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic studies of cytochrome P450 2B1 inactivation by xanthates.
    Yanev SG; Kent UM; Roberts ES; Ballou DP; Hollenberg PF
    Arch Biochem Biophys; 2000 Jun; 378(1):157-66. PubMed ID: 10871056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based inactivation of cytochrome P450 2B1 by 7-ethynylcoumarin: verification of apo-P450 adduction by electrospray ion trap mass spectrometry.
    Regal KA; Schrag ML; Kent UM; Wienkers LC; Hollenberg PF
    Chem Res Toxicol; 2000 Apr; 13(4):262-70. PubMed ID: 10775326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxynitrite inactivation of human cytochrome P450s 2B6 and 2E1: heme modification and site-specific nitrotyrosine formation.
    Lin HL; Myshkin E; Waskell L; Hollenberg PF
    Chem Res Toxicol; 2007 Nov; 20(11):1612-22. PubMed ID: 17907788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of substituted phenyl diaziridines and characterization as mechanism-based inactivators of human cytochrome P450 2B6.
    Sridar C; Kobayashi Y; Brevig H; Kent UM; Puppali SG; Rimoldi JM; Hollenberg PF
    Drug Metab Dispos; 2006 Nov; 34(11):1849-55. PubMed ID: 16882766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 17-alpha-ethynylestradiol-modified active site peptides and glutathione conjugates formed during metabolism and inactivation of P450s 2B1 and 2B6.
    Kent UM; Lin HL; Mills DE; Regal KA; Hollenberg PF
    Chem Res Toxicol; 2006 Feb; 19(2):279-87. PubMed ID: 16485904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of cytochrome P450 2B1 by benzyl isothiocyanate, a chemopreventative agent from cruciferous vegetables.
    Goosen TC; Kent UM; Brand L; Hollenberg PF
    Chem Res Toxicol; 2000 Dec; 13(12):1349-59. PubMed ID: 11123978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of 2-phenyl-2-(1-piperidinyl)propane (ppp), 1,1',1''-phosphinothioylidynetrisaziridine (thioTEPA), clopidogrel, and ticlopidine as selective inactivators of human cytochrome P450 2B6.
    Walsky RL; Obach RS
    Drug Metab Dispos; 2007 Nov; 35(11):2053-9. PubMed ID: 17682072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-based inactivation of rat liver cytochrome P4502B1 by phencyclidine and its oxidative product, the iminium ion.
    Crowley JR; Hollenberg PF
    Drug Metab Dispos; 1995 Aug; 23(8):786-93. PubMed ID: 7493543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism-based inactivation of cytochromes P450 2E1 and 2B1 by 5-phenyl-1-pentyne.
    Roberts ES; Alworth WL; Hollenberg PF
    Arch Biochem Biophys; 1998 Jun; 354(2):295-302. PubMed ID: 9637739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 (P450) isoenzyme specific dealkylation of alkoxyresorufins in rat brain microsomes.
    Dhawan A; Parmar D; Dayal M; Seth PK
    Mol Cell Biochem; 1999 Oct; 200(1-2):169-76. PubMed ID: 10569197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.